Julia Han Noll

3PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 15, 2026
Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy.

|Jan 15, 2026
CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy.

Matthew Ho, Luca Paruzzo, Julia Han Noll

|May 03, 2020
Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy.

Daniel Baumann, Tanja Hägele, Julian Mochayedi

Pageof 1

Frequent Collaborators

2 joint publications

Matthew Ho

2 joint publications

Luca Paruzzo

2 joint publications

Federico Stella

2 joint publications

Marco Ruella